Efficacy of once daily darunavir/ritonavir 800/100 mg in PI/r-experienced HIV-1 infected patients with suppressed HIV-1 replication: the RADAR study - Inserm - Institut national de la santé et de la recherche médicale Access content directly
Conference Papers Journal of the International AIDS Society Year : 2010

Efficacy of once daily darunavir/ritonavir 800/100 mg in PI/r-experienced HIV-1 infected patients with suppressed HIV-1 replication: the RADAR study

Abstract

n.a

Domains

Infectious diseases
Fichier principal
Vignette du fichier
1758-2652-13-S4-P41.pdf (181.46 Ko) Télécharger le fichier
1758-2652-13-S4-P41.xml (7.91 Ko) Télécharger le fichier
Origin : Publisher files allowed on an open archive
Format : Other

Ed. BMC  : Connect in order to contact the contributor

https://www.hal.inserm.fr/inserm-00668432

Submitted on : Thursday, February 9, 2012-5:11:22 PM

Last modification on : Thursday, October 20, 2022-3:10:07 PM

Long-term archiving on: Thursday, May 10, 2012-2:57:51 AM

Download

Dates and versions

inserm-00668432 , version 1 (09-02-2012)

Identifiers

Cite

Jade Ghosn, Aziza Chermak, Allal Houssaini, Gilles Peytavin, Sidonie Lambert-Niclot, et al.. Efficacy of once daily darunavir/ritonavir 800/100 mg in PI/r-experienced HIV-1 infected patients with suppressed HIV-1 replication: the RADAR study. Tenth International Congress on Drug Therapy in HIV Infection, Nov 2010, Glasgow, United Kingdom. pp.P41, ⟨10.1186/1758-2652-13-S4-P41⟩. ⟨inserm-00668432⟩

Export

BibTeX TEI Dublin Core DC Terms EndNote Datacite

Collections

INSERM UPMC UNIV-PARIS-SACLAY SORBONNE-UNIVERSITE SU-MEDECINE
299 View
191 Download

Altmetric

Share

Gmail Facebook Twitter LinkedIn More